5 min read
1 min read
IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis
Learn how our regulatory affairs team was able to work with a sponsor to build a complete, FDA-compliant IND from scratch. Our collaborative efforts led to successful IND submission and initiation of clinical trials with confidence, preventing potential delays and clinical holds.
A sponsor without internal regulatory expertise needed to create and submit an Investigational New Drug (IND) application and turned to Veristat for comprehensive support. They required in-depth regulatory guidance to ensure a compliant IND submission and smooth development process moving forward, knowing that missing or incomplete documentation could cause costly delays.
👉 In this case study, learn how our regulatory team was able to work with the sponsor to solve challenges across numerous areas including:
-
Strategic gap analysis
-
IND planning and management
-
Medical writing coordination
-
Document authoring
-
eCTD publishing
-
FDA submission support
Download our complete case study "IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis"
Get the Latest News
Categories
- Regulatory Consulting (125)
- Regulatory Submissions (120)
- Clinical Trial Regulations (109)
- COVID-19 (46)
- Strategic Consulting (34)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Oncology (12)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Medical Writing (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
6 min read
Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support
May 7, 2025 Veristat Events